Healthcare >> Analyst Interviews >> April 5, 2010

A Close Look At Therapeutics Within Biotech – Matthew L. Kaplan – Ladenburg Thalmann & Co.

MATTHEW L. KAPLAN is Managing Director, Health Care Group - Equity Research, at Ladenburg Thalmann. He focuses on therapeutic companies, cardiovascular and drug delivery. Mr. Kaplan spent 13 years as a Biotechnology Analyst at PZ & Co., Evolution Capital and The Carson Group. He has six years of research experience with the Albert Einstein College of Medicine/Montefiore Hospital Department of Cardiology and has co-authored numerous articles on gene regulation in the heart. Mr. Kaplan holds a B.S. in biology from the University of Michigan. Profile
TWST: What is your coverage within the biotech and pharmaceutical space?

Mr. Kaplan: I cover therapeutic companies in the small- and mid-cap range, with a focus on cardiovascular companies, women's